Wednesday, December 13, 2017

Merry Xmas

Merry Xmas to everyone using Spinnaker  

During the year you randomised patients, published results and initiated new research. 2017 is our biggest year yet with 11 trials on our books. 2017 highlights include:
  • over 5,200 patients were randomised this year using Spinnaker
  • TARGET(Monash) and NovelSTART(MRINZ) completed enrolments 
  • Bryn Gilbertson joined the team to manage TTM2 and TAME
  • we added 2 new servers to our flotilla. We named them Platypus and Discovery (yes there is a new Star Trek series out)
Spiral continues to grow because of what you do. Your projects are the reason we come to work each day and the success of your projects is our most important goal. Thanks for being on board and using our software.
We are having a break over summer but be sure that OUR SUPPORT FOR YOU NEVER STOPS. 

While you are playing cricket on the beach or eating too much ham, our infrastructure team will be monitoring Spinnaker, making sure everything is running smoothly and that your trials can be accessed when you need them.
All the best for the New Year!

Friday, November 17, 2017


Enrolment completed this week!

What a phenomenal achievement from everyone involved in TARGET.  Congratulations because in just 18 months 46 intensive care units in Australia and New Zealand enrolled 4,000 patients.

That's an average of 7.5 patients a day!  

The busiest day was the 4th of August when 25 patients were enrolled. Crazy!

And it wasn’t just enrolling patients and following up … there were so many bags of treatment to reconcile! … and so many large boxes to manage! 

 Congratulations to you all.

Tuesday, November 14, 2017

We layered up our Firewall in the fight against cyber hacking

There has been a firewall protecting our clinical trial servers (and your data) ever since we put our first project in the cloud” in 2013. In the past 5 years we have had no incidents but in our striving for excellence we have gone one step further and added another layer of protection.  

In line with increasing threats and the availability of better protection, we have enhanced our firewall protection with additional layers for DDoS Mitigation, Virtual Patching, and prevention of Zero-Day Exploits. The additional firewall adds an extra level of armour to our servers (yes its a war out there!), will help protect your data and reduces the risk of downtime.  
How will the firewall do all that?
In a nutshell; all traffic for our #1 server is routed through this firewall where suspicious traffic is trashed before legitimate traffic is passed on to #1 server.  In more detail it will: 
  • Block hack attempts. The firewall filters traffic and blocks malicious traffic and attacks
  • Stop brute force attacks. Every application in the cloud gets hit with automated hacker tools known as brute force attacks. If login credentials, for your study, are guessed through one of these attacks hackers can gain access to the application. Our new firewall stops these attacks early.
  • Mitigate DDoS attacks. Distributed Denial of Service attacks can cause downtime for applications. These type of attacks, where multiple computers and multiple internet connections are used to flood the bandwidth on a server, are a nuisance because they prevent legitimate users logging in.
  • Prevent Zero Day Exploits. New vulnerabilities are being discovered by hackers every day. By partnering with firewall experts who have systems to intelligently stop suspicious behaviour we can stop these exploits even if there is no patch.
On with the battle to keep your data safe!

Tuesday, October 31, 2017

TARGET Case Study Published

As the TARGET Trial races towards the successful enrolment of its 4,000 patients, we are pleased to publish a case study of our involvement in the project.

TARGET involves 46 ICU's in both New Zealand and Australia. The trial commenced in 2016, it has been recruiting at extremely high rates. Enrolments will be completed early, certainly by the end of 2017.

 With over 100,000 bags of study treatment supplied as part of this trial, some smart stock management was needed. Spinnaker delivered on that. We are very pleased we have been able to help with streamlining the inventory management, delivery, reconciliation and patient allocation right into the CRF. Hopefully making your job easier.

You can read the full case study on our trial summary page over on the Spinnaker website.   You will also find a PDF of the case study, PDF of the TARGET Fact Sheet and a link to an interview with the Chief Investigator answering questions about the trial.